Crossmark

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Crossref DOI link: https://doi.org/10.1186/s40425-019-0774-y

Published Online: 2019-11-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Safa, Houssein https://orcid.org/0000-0001-6685-4621
Johnson, Daniel H

Trinh, Van Anh

Rodgers, Theresa E

Lin, Heather

Suarez-Almazor, Maria E

Fa’ak, Faisal

Saberian, Chantal

Yee, Cassian

Davies, Michael A

Tummala, Sudhakar

Woodman, Karin

Abdel-Wahab, Noha

Diab, Adi https://orcid.org/0000-0002-0153-0244
License Information

Text and Data Mining valid from 2019-11-21
More Information

Article History

Received: 14 August 2019

Accepted: 5 October 2019

First Online: 21 November 2019

Ethics approval and consent to participate

: The study protocol was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center. IRB number: PA15–0071.

: Not applicable.

: The authors declare that they have no competing interests